INDIVA ANNOUNCES INCENTIVE STOCK OPTION GRANT
Indiva Limited (TSXV: NDVA, OTCQX: NDVAF) announced the granting of 1,680,000 stock options to employees, executive officers, and directors, exercisable at $0.21 per share until June 3, 2027. This issuance is in line with the Company’s amended equity incentive plan, allowing for options up to 10% of the outstanding share capital. Following this granting, Indiva has a total of 14,131,052 stock options issued, representing approximately 9.7% of its total share capital, enhancing employee retention and alignment with shareholder interests.
- Granting of 1,680,000 stock options may improve employee retention and motivation.
- Total stock options issued represent approximately 9.7% of outstanding share capital, indicating effective use of equity incentives.
- None.
LONDON, ON, June 6, 2022 /PRNewswire/ - Indiva Limited (the "Company" or "Indiva") (TSXV: NDVA) (OTCQX: NDVAF), the leading Canadian producer of cannabis edibles and other cannabis products announces that it has granted 1,680,000 incentive stock options (the "Options") to certain employees, executive officers and directors. The Options have an exercise price of
All Options were issued pursuant to the Company's amended and restated equity incentive plan which allows for issuances of up to
Indiva sets the standard for quality and innovation in cannabis. As a Canadian licensed producer, Indiva produces and distributes award-winning cannabis products nationally, including Bhang® Chocolate, Wana™ Sour Gummies, Slow Ride Bakery Cookies, Jewels Chewable Tablets, Ruby® Cannabis Sugar, Grön edibles, Dime IndustriesTM vape products, as well as capsules, edibles, extracts, pre-rolls and premium flower under the INDIVA, Indiva Life and Artisan Batch brands. Click here to connect with Indiva on LinkedIn, Instagram, Twitter and Facebook, and here to find more information on the Company and its products.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) has in any way passed upon the merits of the contents of this press release and neither of the foregoing entities accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this press release.
Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words "could", "intend", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the parties' current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to the Company's future operations, future results, future product offerings and compliance with applicable regulations. Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information. Those assumptions and factors are based on information currently available to the parties. The material factors and assumptions include the parties being able to maintain the necessary regulatory and other third parties' approvals and licensing and other risks associated with regulated entities in the cannabis industry. The forward-looking information contained in this release is made as of the date hereof and the parties are not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward looking information. The foregoing statements expressly qualify any forward-looking information contained herein.
This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.
View original content to download multimedia:https://www.prnewswire.com/news-releases/indiva-announces-incentive-stock-option-grant-301561755.html
SOURCE Indiva Limited
FAQ
What is the significance of the stock options issued by Indiva Limited on June 6, 2022?
What is the exercise price for the stock options granted by Indiva Limited?
Until when are the stock options granted by Indiva Limited valid?
What percentage of Indiva's total share capital is represented by the stock options granted?
Which stock symbols are associated with Indiva Limited?
